Last edition
News about
Recipharm launches new laboratory to expand analytical services offering
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced the completion of a new analytical laboratory at its facility in Bengaluru. The new lab has been in full operation since August 1, 2021
NPPA releases draft version of retail price proposals for 11 drugs
The National Pharmaceutical Pricing Authority (NPPA) has released the draft version of the proposed price calculation sheet for retail price of 11 medicines from various players in the country
Covid 19 treatment: Vir Biotechnology receives AustralianTGA marketing approval for sotrovimab
Vir Biotechnology announced the first marketing authorization, granted in Australia, for its first commercial product, sotrovimab, developed in partnership with GlaxoSmithKline (GSK). This announcement follows news shared by GSK Australia that the Australian Therapeutic Goods Administration (TGA) has granted provisional marketing authorization
Vertex Pharma, Arbor enter new collaboration to develop novel ex vivo engineered cell therapies
Vertex Pharmaceuticals Incorporated, a global biotechnology company, and Arbor Biotechnologies (Arbor), an early-stage life sciences company, announced a new collaboration to enhance efforts in developing ex vivo engineered cell therapies, using Arbor's proprietary CRISPR gene-editing technology for select diseases
India's first mRNA-based vaccine, HGCO19 gets DCGI nod for phase II/III trial
Gennova Biopharmaceuticals Ltd., the Pune-based biotechnology company, submitted the interim clinical data of the phase I study to the Central Drugs Standard Control Organisation (CDSCO), the Government of India's National Regulatory Authority (NRA)
The US Food and Drug Administration (FDA) approved the first covid-19 vaccine. The vaccine has been known as the Pfizer-BioNTech Covid-19 vaccine, and will now be marketed as Comirnaty (koe-mir'-na-tee), for the prevention of Covid-19 disease in individuals 16 years of age and older
Pfizer to acquire Trillium Therapeutics
Pfizer and Trillium Therapeutics yesterday announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer. Under the terms of the agreement
FPME: Pharma exporters ignored under chapter 29 and 30 for RoDTEP rates
The Federation of Pharmaceutical Merchant Exporters and Allied Products (FPME) stated that pharmaceutical exporters are feeling neglected and taken for granted under Remission of Duties and Taxes on Exported Products (RoDTEP), as no rates were announced under chapter 29 and 30 by the Directorate General of Foreign Trade (DGFT)
Vivera Pharmaceuticals, Inc. (Vivera), an innovative, science-driven pharmaceutical company, announced that the US Patent and Trademark Office (USPTO) issued US Patent No. 11,083,850 for Zicoh, the company's wireless, electronic, dose-controlled medication delivery device.
CDSCO declares 44 drug samples as not of standard, one as misbranded in July
The Central Drugs Standard Control Organisation (CDSCO) has declared 44 drug samples out of 1028 it has tested as not of standard quality, during the month of July, 2021. Of the samples tested, 983 were declared as of standard quality
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy